Literature DB >> 17048030

Chemoprevention of bladder cancer.

Dragan J Golijanin1, David Kakiashvili, Ralph R Madeb, Edward M Messing, Seth P Lerner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17048030     DOI： 10.1007/s00345-006-0123-x

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  290 in total

1.  Promutagenic methylation damage in bladder DNA from patients with bladder cancer associated with schistosomiasis and from normal individuals.

Authors:  A F Badawi; M H Mostafa; T Aboul-Azm; N Y Haboubi; P J O'Connor; D P Cooper
Journal:  Carcinogenesis       Date:  1992-05       Impact factor: 4.944

2.  Occupation and cancer of the lower urinary tract.

Authors:  P Cole; R Hoover; G H Friedell
Journal:  Cancer       Date:  1972-05       Impact factor: 6.860

3.  Spontaneous and induced sister chromatid exchanges and delayed cell proliferation in peripheral lymphocytes of Bowen's disease patients and matched controls of arseniasis-hyperendemic villages in Taiwan.

Authors:  Y H Hsu; S Y Li; H Y Chiou; P M Yeh; J C Liou; Y M Hsueh; S H Chang; C J Chen
Journal:  Mutat Res       Date:  1997-06       Impact factor: 2.433

4.  Advances in the etiology of urothelial cancer.

Authors:  A S Morrison
Journal:  Urol Clin North Am       Date:  1984-11       Impact factor: 2.241

5.  Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.

Authors:  E M Messing
Journal:  Cancer Res       Date:  1990-04-15       Impact factor: 12.701

6.  13-cis-retinoic acid in chemoprevention of superficial bladder cancer. The National Bladder Cancer Group.

Authors:  G R Prout; B A Barton
Journal:  J Cell Biochem Suppl       Date:  1992

7.  Consumption of onions and a reduced risk of stomach carcinoma.

Authors:  E Dorant; P A van den Brandt; R A Goldbohm; F Sturmans
Journal:  Gastroenterology       Date:  1996-01       Impact factor: 22.682

8.  Urinary bladder lesions induced by persistent chronic low-dose ionizing radiation.

Authors:  Alina Romanenko; Keiichirou Morimura; Hideki Wanibuchi; Min Wei; Wadim Zaparin; Wladimir Vinnichenko; Anna Kinoshita; Alexander Vozianov; Shoji Fukushima
Journal:  Cancer Sci       Date:  2003-04       Impact factor: 6.716

9.  Human papillomavirus in transitional cell carcinoma of the urinary bladder

Authors: 
Journal:  Clin Cancer Res       Date:  1995-04       Impact factor: 12.531

10.  Risk of internal cancers from arsenic in drinking water.

Authors:  K H Morales; L Ryan; T L Kuo; M M Wu; C J Chen
Journal:  Environ Health Perspect       Date:  2000-07       Impact factor: 9.031
View more
  9 in total

1.  A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer.

Authors:  Anita L Sabichi; J Jack Lee; H Barton Grossman; Suyu Liu; Ellen Richmond; Bogdan A Czerniak; Jorge De la Cerda; Craig Eagle; Jaye L Viner; J Lynn Palmer; Seth P Lerner
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-31

Review 2.  Urothelial carcinoma of the bladder: definition, treatment and future efforts.

Authors:  Sandip M Prasad; G Joel Decastro; Gary D Steinberg
Journal:  Nat Rev Urol       Date:  2011-10-11       Impact factor: 14.432

3.  A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.

Authors:  Edward Messing; Jason R Gee; Daniel R Saltzstein; KyungMann Kim; Anthony diSant'Agnese; Jill Kolesar; Linda Harris; Adrienne Faerber; Thomas Havighurst; Jay M Young; Mitchell Efros; Robert H Getzenberg; Marcia A Wheeler; Joseph Tangrea; Howard Parnes; Margaret House; J Erik Busby; Raymond Hohl; Howard Bailey
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-31

4.  Personalized therapy for urothelial cancer: review of the clinical evidence.

Authors:  Elizabeth A Guancial; Dipanjan Chowdhury; Jonathan E Rosenberg
Journal:  Clin Investig (Lond)       Date:  2011-04

5.  Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell lines via inhibition of the mTOR pathway and induction of autophagy.

Authors:  Zhongbo Liu; Xuesen Li; Anne R Simoneau; Mahtab Jafari; Xiaolin Zi
Journal:  Mol Carcinog       Date:  2011-04-22       Impact factor: 4.784

6.  Functional and molecular characterization of kinin B1 and B 2 receptors in human bladder cancer: implication of the PI3Kγ pathway.

Authors:  V Sgnaolin; T C B Pereira; M R Bogo; R Zanin; A M O Battastini; F B Morrone; M M Campos
Journal:  Invest New Drugs       Date:  2012-12-07       Impact factor: 3.850

7.  Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression.

Authors:  Stephanie Tseng-Rogenski; Jason Gee; Kathleen Woods Ignatoski; Lakshmi P Kunju; Amanda Bucheit; Hallie J Kintner; David Morris; Christopher Tallman; Joshua Evron; Christopher G Wood; H Barton Grossman; Cheryl T Lee; Monica Liebert
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

Review 8.  Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach.

Authors:  Andrew Leone; Gregory Diorio; Wade Sexton; Michael Schell; Mark Alexandrow; Jed W Fahey; Nagi B Kumar
Journal:  Oncotarget       Date:  2017-05-23

9.  Characteristic patterns of microRNA expression in human bladder cancer.

Authors:  Anastasia A Zabolotneva; Alex Zhavoronkov; Andrew V Garazha; Sergey A Roumiantsev; Anton A Buzdin
Journal:  Front Genet       Date:  2013-01-04       Impact factor: 4.599
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.